(Q37756123)

English

Risperidone long-acting injection: in bipolar I disorder

scientific article published on May 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

1 reference

Europe PubMed Central

Risperidone long-acting injection: in bipolar I disorder (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

1 reference

based on heuristic

inferred from title

1

object named as

Emma D Deeks

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

publication date

1 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

70

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

1001-1012

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of bipolar depression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-acting risperidone: a review of its use in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone: a review of its use in the treatment of bipolar mania

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic profile of long-acting injectable risperidone at steady-state: comparison with oral administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The management of individuals with bipolar disorder: a review of the evidence and its integration into clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone long-acting injection: pharmacokinetics following administration in deltoid versus gluteal muscle in schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta) in patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor pharmacology of neuroleptics: relation to clinical effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absorption, metabolism, and excretion of risperidone in humans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-acting risperidone: a review of its role in the treatment of bipolar disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/20481656

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11204480-000000000-00000

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37756123&oldid=2200916978"